RA Capital Management - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$10,331,000
-27.8%
584,0000.0%0.17%
-23.1%
Q1 2021$14,308,000
-27.6%
584,0000.0%0.22%
-21.7%
Q4 2020$19,768,000584,0000.28%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 602,272$2,698,0008.92%
Column Group LLC 3,568,181$15,985,0003.40%
Euclidean Capital LLC 747,550$3,349,0002.85%
Invus Financial Advisors, LLC 1,007,575$4,514,0002.72%
SILVERARC CAPITAL MANAGEMENT, LLC 1,082,304$4,849,0001.49%
Monaco Asset Management SAM 364,741$1,634,0000.71%
EcoR1 Capital, LLC 3,418,068$15,313,0000.53%
DAFNA Capital Management LLC 415,926$1,863,0000.51%
Boxer Capital, LLC 1,054,000$4,722,0000.30%
Casdin Capital, LLC 601,515$2,695,0000.23%
View complete list of ORIC PHARMACEUTICALS INC shareholders